Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION (DHR)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 10/23 09:15:12 pm
97.73 USD   -0.84%
10/18DANAHER : Raises Guidance on Rising Profits
DJ
10/18DANAHER : 3Q Earnings Snapshot
AQ
10/18DANAHER : Reports Third Quarter 2018 Results
PR
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Danaher Corporation : Danaher to Present at J.P. Morgan Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/02/2013 | 10:27pm CEST
Danaher to Present at J.P. Morgan Healthcare Conference

Washington, D.C., January 2, 2013 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2013 at 3:00 p.m. PST. The audio will be simultaneously webcast on www.danaher.com. A replay of the webcast will be available for one week following the presentation.

* * *

Danaher is a science and technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.  Our premier brands are among the most highly recognized in each of the markets we serve.  The Danaher Business System provides a foundation to our 59,000 associates around the world, serving customers in more than 125 countries.  In 2011, we generated $16.1 billion of revenue. www.danaher.com.

Please contact:

Matt R. McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W

Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860


HUG#1667858


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
10/18DANAHER : Raises Guidance on Rising Profits
DJ
10/18DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
10/18DANAHER : 3Q Earnings Snapshot
AQ
10/18DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
10/18DANAHER : Reports Third Quarter 2018 Results
PR
10/18DANAHER CORPORATION : Slide show Q3 results
CO
10/18DANAHER CORPORATION : 3rd quarter results
CO
10/15DANAHER CORPORATION : quaterly earnings release
10/02For First Time, GE Turns to an Outsider -- WSJ
DJ
10/02GE Ousts John Flannery as CEO After Missed Targets--9th Update
DJ
More news
News from SeekingAlpha
10/22Buy Danaher For Total Return And 9% Yearly Growth 
10/18Danaher Corporation (DHR) CEO Tom Joyce on Q3 2018 Results - Earnings Call 
10/18Danaher Corporation 2018 Q3 - Results - Earnings Call Slides 
10/18Dental equipment supplies may be soft after Danaher Q3 results - Evercore 
10/18Danaher Corporation beats by $0.02, beats on revenue 
Financials ($)
Sales 2018 19 832 M
EBIT 2018 4 011 M
Net income 2018 2 645 M
Debt 2018 8 932 M
Yield 2018 0,63%
P/E ratio 2018 26,56
P/E ratio 2019 24,20
EV / Sales 2018 3,93x
EV / Sales 2019 3,62x
Capitalization 69 081 M
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 115 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Steven M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION6.18%70 843
THERMO FISHER SCIENTIFIC19.63%92 526
INTUITIVE SURGICAL40.14%59 409
BOSTON SCIENTIFIC CORPORATION47.72%51 901
ILLUMINA45.19%47 253
ROYAL PHILIPS0.59%38 348